Autonomic Nervous System Drugs Practice Questions

Q: Which of the following is not a common side effect of clonidine?

Diarrhea. ***Diarrhea*** - **Clonidine** commonly causes **constipation**, not diarrhea, due to its **alpha-2 adrenergic agonist** effects, which decrease gastrointestinal motility. - Diarrhea is not typically associated with clonidine's mechanism of action or adverse effect profile. *Xerostomia* - **Xerostomia** (dry mouth) is a very common side effect of **clonidine** occurring in up to 40% of patients. - This results from **alpha-2 agonist** activity that reduces sympathetic stimulation of salivary gland secretions. - This symptom can significantly impact patient compliance and quality of life. *Sedation* - **Sedation** is a frequent side effect of **clonidine**, particularly when initiating treatment or increasing dosage, because it acts as an **alpha-2 agonist** in the central nervous system, reducing sympathetic outflow and promoting drowsiness. - Patients are often advised to avoid driving or operating heavy machinery until they know how the medication affects them. *Impotency* - **Impotency** or **erectile dysfunction** is a recognized and common sexual side effect of **clonidine**, which can interfere with quality of life and adherence to treatment for hypertension. - This effect is related to the drug's impact on the autonomic nervous system and vascular tone through central alpha-2 agonism.

Q: Which non-selective beta-blocker has sympathomimetic activity?

Pindolol. ***Pindolol*** - **Pindolol** is a **non-selective beta-blocker** that exhibits **intrinsic sympathomimetic activity (ISA)**, meaning it acts as a partial agonist at beta-adrenergic receptors. - Due to ISA, it causes less reduction in resting heart rate and cardiac output compared to beta-blockers without ISA. *Acebutalol* - **Acebutalol** is a **beta-1 selective blocker** (cardioselective) that possesses **intrinsic sympathomimetic activity (ISA)**. - While it has ISA, it is not a non-selective beta-blocker, making it an incorrect answer for this question. *Nadolol* - **Nadolol** is a **non-selective beta-blocker** that does **not** have intrinsic sympathomimetic activity (ISA). - It primarily acts as a pure antagonist at both beta-1 and beta-2 adrenergic receptors. *Metoprolol* - **Metoprolol** is a **beta-1 selective blocker** (cardioselective) and does **not** possess intrinsic sympathomimetic activity (ISA). - Its primary action is blockade of cardiac beta-1 receptors.

Q: Which is the longest acting anti-cholinesterase?

Echothiophate. ***Echothiophate*** - **Echothiophate** is an **organophosphate** compound that irreversibly inhibits acetylcholinesterase, leading to a prolonged duration of action, often measured in weeks. - Due to its **long-acting** and irreversible nature, it is primarily used in ophthalmic preparations for glaucoma but is not commonly used systemically. *Pyridostigmine* - **Pyridostigmine** is a medium-acting anticholinesterase, typically lasting **3-6 hours**, and is commonly used for the chronic management of **myasthenia gravis**. - Its effects are **reversible**, binding to the enzyme for a limited period. *Ambenonium* - **Ambenonium** has a longer duration of action than pyridostigmine, typically lasting **4-8 hours**, but is still considered a reversible inhibitor. - It was historically used for **myasthenia gravis** but is now less common due to the availability of other effective treatments. *Edrophonium* - **Edrophonium** is a very short-acting anticholinesterase, with effects lasting only **5-15 minutes**, making it ideal for the **Tensilon test** to diagnose myasthenia gravis and differentiate between myasthenic and cholinergic crises. - Its rapid onset and brief duration are due to its **reversible** and transient binding to acetylcholinesterase.

Q: Which anti-cholinesterase drug is known for its central nervous system activity?

Physostigmine. ***Physostigmine*** - Unlike most other anti-cholinesterases, **physostigmine** is a **tertiary amine** and is relatively lipid-soluble, allowing it to cross the **blood-brain barrier**. [2] - Its ability to increase acetylcholine in the CNS makes it useful in treating anticholinergic toxicity (e.g., atropine overdose). [2] *Pyridostigmine* - **Pyridostigmine** is a **quaternary amine** and does not readily cross the blood-brain barrier, primarily acting peripherally. - It is mainly used in the long-term management of **myasthenia gravis**. *Edrophonium* - **Edrophonium** is a very short-acting **quaternary amine** that does not cross the blood-brain barrier. [1] - It is primarily used for the **diagnosis of myasthenia gravis** (Tensilon test) due to its rapid onset and short duration of action. [1] *Neostigmine* - **Neostigmine** is also a **quaternary amine** with poor lipid solubility, meaning it has minimal central nervous system activity. [2] - It is commonly used to reverse the effects of **non-depolarizing neuromuscular blockers** and in the treatment of **myasthenia gravis**.

Q: Which of the following is an action of muscarinic cholinergic receptors?

Decreased heart rate. ***Decreased heart rate*** - Activation of **muscarinic cholinergic receptors (M2 receptors)** in the heart leads to a decrease in heart rate and conduction velocity. - This effect is mediated by the **vagus nerve (parasympathetic nervous system)**, which releases acetylcholine to act on these receptors. - This is the **most characteristic and clinically significant cardiovascular effect** of muscarinic receptor activation, making it the expected answer. *Skeletal muscle contraction* - **Skeletal muscle contraction** is mediated by **nicotinic acetylcholine receptors (nAChRs)** at the **neuromuscular junction**, NOT muscarinic receptors. - Nicotinic receptors are **ligand-gated ion channels** that cause direct depolarization and muscle contraction when activated. - This is the only option that is **NOT a muscarinic receptor action**. *Acid secretion in stomach* - **Gastric acid secretion** IS mediated by **M3 muscarinic receptors** on parietal cells. - Acetylcholine from the vagus nerve directly stimulates parietal cells and also stimulates histamine release from enterochromaffin-like cells. - While this is a valid muscarinic action, in the context of distinguishing muscarinic effects, **cardiac effects** (decreased heart rate) are more emphasized as the classic teaching point. *Salivation and lacrimation* - **Salivation and lacrimation** ARE mediated by **M3 muscarinic receptors** in exocrine glands. - These are classic parasympathetic/muscarinic effects taught in physiology. - However, when distinguishing key muscarinic actions, **M2 receptor-mediated cardiac effects** are typically highlighted as the primary cardiovascular manifestation, while M3 effects on glands are secondary teaching points.

Q: Beta2-agonists cause all except:

Hyperkalemia. ***Hyperkalemia*** - Beta2-agonists actually cause **hypokalemia**, not hyperkalemia, by promoting the intracellular shift of potassium. - This effect is due to the stimulation of the **Na+/K+-ATPase pump** by beta-2 adrenergic receptors. *Hyperglycemia* - Beta2-agonists can lead to **hyperglycemia** by promoting glycogenolysis and gluconeogenesis in the liver. - They also decrease **insulin secretion** and increase insulin resistance. *Tremor* - **Tremor** is a common side effect of beta2-agonists, particularly in the hands, due to direct stimulation of beta2 receptors on skeletal muscle. - This muscle stimulation leads to increased muscle twitching and a fine tremor. *Palpitation* - **Palpitations** can occur due to the systemic absorption of beta2-agonists, leading to activation of beta1 receptors in the heart. - This can cause **tachycardia** and a sensation of a racing heart.

Q: Which class of drugs does botulinum toxin mimic in its action?

Anticholinergics. ***Anticholinergics*** - **Botulinum toxin** inhibits the release of **acetylcholine** from **presynaptic nerve terminals** [2] by preventing vesicle fusion, leading to muscle paralysis [1]. - While the **mechanism differs** (botulinum acts presynaptically, anticholinergics act postsynaptically at receptors), the **functional outcome** is similar: reduced cholinergic neurotransmission. - In terms of **clinical effect** at the neuromuscular junction, both reduce acetylcholine's action, making anticholinergics the closest functional parallel among the given options. *Cholinergics* - **Cholinergics** enhance acetylcholine activity, either by increasing its release, mimicking its effects at receptors, or inhibiting its breakdown. - This is the **opposite** of botulinum toxin's action, which reduces acetylcholine's impact. *Adrenergics* - **Adrenergics** stimulate the **sympathetic nervous system** via **adrenergic receptors** (α and β receptors). - They act on **norepinephrine/epinephrine pathways**, not the cholinergic system where botulinum toxin acts. *Antiadrenergic* - **Antiadrenergic drugs** block **adrenergic receptors** or inhibit sympathetic activity. - These are unrelated to botulinum toxin's effect on **cholinergic neuromuscular transmission**.

Q: What is the drug of choice for pheochromocytoma?

Phenoxybenzamine. ***Phenoxybenzamine*** - This is an **irreversible, non-selective alpha-adrenergic blocker**, which is the drug of choice for preparing patients for surgical removal of a pheochromocytoma. - It effectively controls **hypertension** by blocking the effects of catecholamines on blood vessels, preventing a hypertensive crisis during surgery. *Propranolol* - **Beta-blockers** like propranolol should **not be used as monotherapy** in pheochromocytoma because blocking beta-2 receptors without prior alpha blockade can lead to unopposed alpha-adrenergic vasoconstriction and precipitate a **hypertensive crisis**. - It can be added **after adequate alpha-blockade** to control tachycardia. *Prazosin* - Prazosin is a **reversible, selective alpha-1 adrenergic blocker**, which is not preferred over phenoxybenzamine due to its shorter duration of action and reversibility. - While it can lower blood pressure, its efficacy in preventing hypertensive crises during surgery for pheochromocytoma is **less robust** compared to phenoxybenzamine. *Nitroprusside* - Sodium nitroprusside is a **potent vasodilator** often used for **hypertensive emergencies**, but it is not the drug of choice for long-term management or preoperative preparation in pheochromocytoma. - Its use in pheochromocytoma is typically reserved for **acute hypertensive crises** when other agents are insufficient, rather than initial management.

Q: Botulinum toxin acts on

Synapse. ***Synapse*** - **Botulinum toxin** acts by inhibiting the release of **acetylcholine** at the **neuromuscular junction**, which is a type of synapse. - This blockade of neurotransmitter release at the **presynaptic terminal** prevents muscle contraction, leading to paralysis. *Smooth muscle of intestine* - While botulinum toxin can affect smooth muscle indirectly by paralyzing the motor nerves innervating them, its primary site of action is the **synapse** itself, not directly on the muscle fibers. - The toxin primarily targets the nerve endings, rather than the mechanical contractility of the muscle cell. *Central nervous system* - **Botulinum toxin** does not readily cross the **blood-brain barrier**, meaning its primary effects are peripheral. - Its therapeutic and toxic effects are localized to the **peripheral nervous system** and neuromuscular junctions. *Sensory nerves* - **Botulinum toxin** specifically targets **motor nerve endings** to inhibit acetylcholine release, leading to muscle paralysis. - It does not directly affect the function of **sensory nerve transmission** or pain perception in the same way.

Q: Botulinum toxin type B is used in which disease?

Cervical dystonia. ***Cervical dystonia*** * **Botulinum toxin type B (Myobloc/NeuroBloc)** is specifically approved for the treatment of **cervical dystonia**, which involves involuntary contractions of neck muscles. * It works by blocking the release of **acetylcholine** at the neuromuscular junction, leading to muscle relaxation. *Strabismus* * **Botulinum toxin type A (Botox, Dysport, Xeomin)** is the preferred and most commonly used form for treating **strabismus** by temporarily weakening specific extraocular muscles. * Type B is generally not indicated for strabismus due to differences in potency and duration of action. *Blepharospasm* * **Botulinum toxin type A** (e.g., Botox) is the primary treatment for **blepharospasm**, an involuntary forceful closure of the eyelids. * While both types inhibit acetylcholine release, type A has a more established and concentrated use in treating localized muscle spasms like blepharospasm. *Glabellar lines* * **Botulinum toxin type A** is widely used for cosmetic applications such as reducing **glabellar lines** (frown lines between the eyebrows). * Its efficacy and safety for cosmetic indications are well-established, making type A the standard choice over type B.

Question 1

Which of the following is not a common side effect of clonidine?

Accepted Answer

Diarrhea

Answer

Xerostomia

Answer

Sedation

Answer

Impotency

Question 2

Which non-selective beta-blocker has sympathomimetic activity?

Accepted Answer

Pindolol

Answer

Nadolol

Answer

Acebutalol

Answer

Metoprolol

Question 3

Which is the longest acting anti-cholinesterase?

Accepted Answer

Echothiophate

Answer

Pyridostigmine

Answer

Ambenonium

Answer

Edrophonium

Question 4

Which anti-cholinesterase drug is known for its central nervous system activity?

Accepted Answer

Physostigmine

Answer

Edrophonium

Answer

Pyridostigmine

Answer

Neostigmine

Question 5

Which of the following is an action of muscarinic cholinergic receptors?

Accepted Answer

Decreased heart rate

Answer

Skeletal muscle contraction

Answer

Acid secretion in stomach

Answer

Salivation and lacrimation

Question 6

Beta2-agonists cause all except:

Accepted Answer

Hyperkalemia

Answer

Hyperglycemia

Answer

Tremor

Answer

Palpitation

Question 7

Which class of drugs does botulinum toxin mimic in its action?

Accepted Answer

Anticholinergics

Answer

Adrenergics

Answer

Antiadrenergic

Answer

Cholinergics

Question 8

What is the drug of choice for pheochromocytoma?

Accepted Answer

Phenoxybenzamine

Answer

Propranolol

Answer

Prazosin

Answer

Nitroprusside

Question 9

Botulinum toxin acts on

Accepted Answer

Synapse

Answer

Smooth muscle of intestine

Answer

Central nervous system

Answer

Sensory nerves

Question 10

Botulinum toxin type B is used in which disease?

Accepted Answer

Cervical dystonia

Answer

Blepharospasm

Answer

Strabismus

Answer

Glabellar lines

Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?